Clinical Trial Update: A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Miebo’s impact on preoperative biometry/keratometry and postoperative refractive accuracy; the study sponsored by Bausc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Miebo (perfluorohexyloctane ophthalmic solution)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye | Phase 4 | Status: COMPLETED